Prostate-specific antigen responses were similar between transdermal estradiol and hormone therapy combined with androgen receptor inhibitors in prostate cancer.
Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone ...
Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...